| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $34.19B | $35.44B | $34.23B | $33.67B | $27.13B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $2.68B | $2.48B | $2.23B | – | $398.38M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $705.56M | $1.22B | $1.24B | $1.37B | $1.36B |
| Net Income | $2.08B | $3.93B | $3.94B | $4.61B | $4.43B |
| EPS (basic) | 7.9800 | 14.3100 | 13.7300 | 15.7400 | 14.2800 |
| EPS (diluted) | – | 14.3100 | 13.7300 | 15.7200 | 14.2700 |
| Shares (diluted) | – | $272.02M | $283.32M | $289.82M | $306.61M |